Liquid Biopsy (OncoSELECT Kit)
Targeted Liquid Biopsy to Support Your Clinical Decisions
The OncoSELECT Kit is OncoDNA’s first decentralised RUO (Research Use Only) solution for liquid biopsies , it benefits from having been used in a routine centralised setting for many years ensuring that laboratories can leverage OncoDNA’s extensive expertise locally. The OncoSELECT Kit encompasses more than 70 genes, including pertinent HRR genes, reporting genomic alterations and enabling the identification of MSI and CNV.
When a solid biopsy is impossible or unavailable, the OncoSELECT Kit is recommended as a non-invasive solution to detect ctDNA in the blood of cancer patients. Underpinning the kit is Twist Bioscience reagents, and OncoDNA’s data analysis and clinical interpretation tool, OncoKDMTM. Using the data gathered in OncoKDMTM, molecular biologists can create a report that will ensure oncologists increase patient access to precision oncology.
10 years of knowledge that matters
Since 2013, OncoDNA has performed more than 35,000 tests, enabling us to build a comprehensive database (OncoKDO®) comprising 4,5 million variants across 22,000 genes, along with information on 1,400 drugs and 9,000 clinical trials. This vast repository of information allows OncoDNA to provide our clients with the most accurate and up-to-date molecular profiling for personalized cancer treatment.
A unique capture method for high quality data with less sequencing
OncoSELECT® Kit uses a unique Twist Biosciences’ capture method allowing high coverage and uniformity with less DNA input and less sequencing needed.
An easy process automatization
Thanks to the compatibility with Illumina’s technology, the easy automation process simplifies tasks by continuing using the current tools without disturbing the automate routine activities and losing time in extra training and manipulations.
Compatible with Illumina Technology
Achieving high-performance sequencing is now more accessible than ever, thanks to the OncoSELECT® Kit and Illumina sequencers. By utilizing these cutting-edge technologies, laboratories can process multiple samples per flow cell, as outlined in the Table above. This streamlined process allows faster and more efficient sequencing, resulting in more accurate data and better outcomes.
From sample preparation to clinical insights in just 5 days
OncoSELECT® Kit revolutionizes the diagnostic process by significantly reducing the timeline from DNA extraction to clinical and biological interpretation to just 5 days. This accelerated timeframe enables healthcare professionals to make faster decisions, resulting in enhanced patient care and improved outcomes.
Clear data insight and clinical interpretation
OncoKDM® ’s comprehensive interpretation reports provide labs with eight essential assets to enhance the understanding of NGS data, including detailed annotations, a list of actionable variants, a list of therapies recommendation and a summary of relevant clinical trials.
